FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380264443> ?p ?o ?g. }

• W4380264443 abstract "Purpose: To assess functional and anatomical outcomes of intravitreal anti-Vascular Endothelial Growth Factor (anti-VEGF) monotherapy versus combined with verteporfin Photodynamic Therapy (PDT) for Retinal Angiomatous Proliferation (RAP). Methods: Studies reporting outcomes of intravitreal anti-VEGF monotherapy and/or in combination with verteporfin PDT in RAP eyes with a follow-up ≥ 12 months were searched. The primary outcome was the mean change in best corrected visual acuity (BCVA) at 12 months. Mean change in central macular thickness (CMT) and mean number of injections were considered as secondary outcomes. The mean difference (MD) between pre- and post-treatment values was calculated along with 95% Confidence Interval (95% CI). Meta-regressions were performed to assess the influence of anti-VEGF number of injections on BCVA and CMT outcomes. Results: Thirty-four studies were included. A mean gain of 5.16 letters (95% CI = 3.30-7.01) and 10.38 letters (95% CI = 8.02-12.75) was shown in the anti-VEGF group and combined group, respectively (anti-VEGF group vs. combined group, p < 0.01). A mean CMT reduction of 132.45 µm (95% CI = from -154.99 to -109.90) and 213.93 µm (95% CI = from -280.04 to -147.83) was shown in the anti-VEGF group and combined group, respectively (anti-VEGF group vs. combined group, p < 0.02). A mean of 4.9 injections (95% CI = 4.2-5.6) and 2.8 injections (95% CI = 1.3-4.4) were administered over a 12-month period in the anti-VEGF group and combined group, respectively. Meta-regression analyses showed no influence of injection number on visual and CMT outcomes. High heterogeneity was found across studies for both functional and anatomical outcomes. Conclusion: A combined approach with anti-VEGF and PDT could provide better functional and anatomical outcomes in RAP eyes compared with anti-VEGF monotherapy." @default.
• W4380264443 created "2023-06-12" @default.
• W4380264443 creator A5004087638 @default.
• W4380264443 creator A5009720671 @default.
• W4380264443 creator A5017028131 @default.
• W4380264443 creator A5025584126 @default.
• W4380264443 creator A5025992002 @default.
• W4380264443 creator A5033560303 @default.
• W4380264443 creator A5039532395 @default.
• W4380264443 creator A5048516826 @default.
• W4380264443 creator A5054485016 @default.
• W4380264443 creator A5062682571 @default.
• W4380264443 creator A5064880363 @default.
• W4380264443 creator A5070063314 @default.
• W4380264443 creator A5078854483 @default.
• W4380264443 creator A5080069172 @default.
• W4380264443 creator A5080173073 @default.
• W4380264443 creator A5087414533 @default.
• W4380264443 creator A5090000646 @default.
• W4380264443 date "2023-06-12" @default.
• W4380264443 modified "2023-09-26" @default.
• W4380264443 title "Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis" @default.
• W4380264443 cites W1601975653 @default.
• W4380264443 cites W1876804540 @default.
• W4380264443 cites W1970699493 @default.
• W4380264443 cites W1986060789 @default.
• W4380264443 cites W1988158731 @default.
• W4380264443 cites W1988711529 @default.
• W4380264443 cites W1990850867 @default.
• W4380264443 cites W1998386860 @default.
• W4380264443 cites W2002572401 @default.
• W4380264443 cites W2004006153 @default.
• W4380264443 cites W2012601628 @default.
• W4380264443 cites W2012897052 @default.
• W4380264443 cites W2017044005 @default.
• W4380264443 cites W2019036959 @default.
• W4380264443 cites W2046105620 @default.
• W4380264443 cites W2046122510 @default.
• W4380264443 cites W2048729639 @default.
• W4380264443 cites W2054908093 @default.
• W4380264443 cites W2064501648 @default.
• W4380264443 cites W2070461167 @default.
• W4380264443 cites W2074013967 @default.
• W4380264443 cites W2080677442 @default.
• W4380264443 cites W2091470943 @default.
• W4380264443 cites W2092513931 @default.
• W4380264443 cites W2100101997 @default.
• W4380264443 cites W2124854049 @default.
• W4380264443 cites W2134833483 @default.
• W4380264443 cites W2142838015 @default.
• W4380264443 cites W2217372040 @default.
• W4380264443 cites W2325448373 @default.
• W4380264443 cites W2327332319 @default.
• W4380264443 cites W2398483411 @default.
• W4380264443 cites W2470458903 @default.
• W4380264443 cites W2543252747 @default.
• W4380264443 cites W2574750402 @default.
• W4380264443 cites W2587055868 @default.
• W4380264443 cites W2596268292 @default.
• W4380264443 cites W2762832323 @default.
• W4380264443 cites W2803120053 @default.
• W4380264443 cites W2902045072 @default.
• W4380264443 cites W2941083261 @default.
• W4380264443 cites W2946064166 @default.
• W4380264443 cites W2948088537 @default.
• W4380264443 cites W2951920635 @default.
• W4380264443 cites W2979162070 @default.
• W4380264443 cites W2991540252 @default.
• W4380264443 cites W2994341415 @default.
• W4380264443 cites W3011335822 @default.
• W4380264443 cites W3016634861 @default.
• W4380264443 cites W3043747921 @default.
• W4380264443 cites W3084811187 @default.
• W4380264443 cites W3095700978 @default.
• W4380264443 cites W3112910910 @default.
• W4380264443 cites W3132158873 @default.
• W4380264443 cites W4200334822 @default.
• W4380264443 cites W4238428323 @default.
• W4380264443 cites W4251857773 @default.
• W4380264443 cites W4293773311 @default.
• W4380264443 doi "https://doi.org/10.3389/fphar.2023.1141077" @default.
• W4380264443 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37377929" @default.
• W4380264443 hasPublicationYear "2023" @default.
• W4380264443 type Work @default.
• W4380264443 citedByCount "0" @default.
• W4380264443 crossrefType "journal-article" @default.
• W4380264443 hasAuthorship W4380264443A5004087638 @default.
• W4380264443 hasAuthorship W4380264443A5009720671 @default.
• W4380264443 hasAuthorship W4380264443A5017028131 @default.
• W4380264443 hasAuthorship W4380264443A5025584126 @default.
• W4380264443 hasAuthorship W4380264443A5025992002 @default.
• W4380264443 hasAuthorship W4380264443A5033560303 @default.
• W4380264443 hasAuthorship W4380264443A5039532395 @default.
• W4380264443 hasAuthorship W4380264443A5048516826 @default.
• W4380264443 hasAuthorship W4380264443A5054485016 @default.
• W4380264443 hasAuthorship W4380264443A5062682571 @default.
• W4380264443 hasAuthorship W4380264443A5064880363 @default.
• W4380264443 hasAuthorship W4380264443A5070063314 @default.
• W4380264443 hasAuthorship W4380264443A5078854483 @default.
• W4380264443 hasAuthorship W4380264443A5080069172 @default.

• next